arrow_back Back to App

Easier Drug Access: Ending Unnecessary Step Therapy Trials

New rules make it easier for patients to get the medications their doctor deems best, without having to go through ineffective or harmful treatments first. Health insurers must implement clear processes for patients to appeal step therapy requirements, with faster decisions, especially in emergencies. This means treatment will be more tailored to individual needs, and patients will receive appropriate help more quickly.
Key points
Health insurers must establish an appeal process for step therapy requirements before accessing prescribed medications.
Patients can appeal if previous drugs were ineffective, harmful, treatment delay poses serious consequences, or if the drug is essential for daily functioning.
Appeal decisions will be made quickly: within 72 hours for standard cases and 24 hours for life-threatening emergencies.
Information about the appeal process must be readily available on health insurers' websites.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_464
Sponsor: Sen. Murkowski, Lisa [R-AK]
Process start date: 2021-02-25